BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 17, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for April 21, 2020

April 21, 2020
New hires and promotions in the biopharma industry, including: Abeona, ADC, Adverum, Applied Molecular Transport, Arch, Cocrystal, Geneuro, Hemostemix, Kineta, Nellone, Oculis, Outlook, Rockwell, Sangamo.
Read More

Regulatory actions for April 20, 2020

April 20, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytosorbents, Endospan, Fosun Pharma, Foundation Medicine, Genosensor, Osang Healthcare.
Read More

In the clinic for April 20, 2020

April 20, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Myriad Genetics.
Read More

Financings for April 20, 2020

April 20, 2020
Med-tech firms raising money in public or private financings, including: Check-Cap, Pi-Cardia.
Read More

Other news to note for April 20, 2020

April 20, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3a-Diagnostics, Amblyotech, Assure Holdings, Avita Medical, Aytu Bioscience, Causaly, Epion Health, Medable, Median Technologies, Merit Medical, Microbac Laboratories, Midwest Products & Engineering, Mologic, Nanopass, Novabay Pharmaceuticals, Novartis, Omega Diagnostics, PDI Healthcare, Renalytix, Shenzhen Microprofit Biotech, Strata Skin Sciences, Tissue Regenix, Twist Bioscience, Ubisoft, Xphyto.
Read More

Appointments and advancements for April 20, 2020

April 20, 2020
New hires and promotions in the med-tech industry, including: Gtx Medical, Nihon Kohden.
Read More

Regulatory actions for April 20, 2020

April 20, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4D, Futura, Genentech, Mustang, Precigen.
Read More

Other news to note for April 20, 2020

April 20, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alligator, Anixa, Bayer, CB, Chromadex, Compugen, Cue, Cyclacel, Epsilogen, Esperion, Helsinn, Inmune, Innocan, Melinta, Merck, Molecular Partners, Noxxon, Otsuka, Recce Pharmaceuticals, Som Biotech, Theravance Biopharma.
Read More

In the clinic for April 20, 2020

April 20, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alexion, Ascendis, BMS, Idorsia, Incyte, Karyopharm, Novartis, Xeris.
Read More

Financings for April 20, 2020

April 20, 2020
Biopharmas raising money in public or private financings, including: Crinetics Pharmaceuticals, Oric Pharmaceuticals, Zikani Therapeutics.
Read More
Previous 1 2 … 1561 1562 1563 1564 1565 1566 1567 1568 1569 … 1717 1718 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Kim Woo-youn, CEO and cofounder, Hits

    Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery

    BioWorld Science
    Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing